The Commission on Future Research Priorities in the USA sets out 13 key priority areas to help focus the $2 billion of funding released to the NCI.
Practice & Policy
An increase in the number of approved cancer therapeutics has led to an associated increase in early-phase trials that have adopted a seamless approach.
When presented with different options, patients perceived physicians that communicated face to face without the use of a computer as being more compassionate, professional, and as having better communication skills.
In this interview we discuss health disparities in cancer care, how redesigning cancer clinical trials can address some of these disparities, and goals for the “next generation” of cancer health disparities research.
From 1989 to 2015, breast cancer death rates decreased by 39%, according to findings from a report from the American Cancer Society. This decrease translates to well over a quarter of a million averted breast cancer deaths in the United States.
A substantially higher number of nonelderly patients with newly diagnosed cancer had insurance after implementation of the Affordable Care Act, according to the results of a new study.
So-called “narrow network” healthcare plans are more likely to exclude oncologists who are associated with NCI-designated or NCCN Cancer Centers, according to a new study.
In this interview we discuss the issue of burnout in oncology, including signs and risk factors, how it might affect patient care, and strategies for prevention.
The FDA has announced a new comprehensive plan for tobacco and nicotine regulation designed to serve as a road map to better protect American children and reduce tobacco-related disease and death.
More privately insured cancer patients seeking to participate in clinical trials received approval since the passage of the Affordable Care Act, according to a new study.